Ekso Bionics Holdings, Inc. Common Stock —— 图表、价格与新闻 (NASDAQ:EKSO)

展开完整图表

Financials

概览声明统计

每季度年度

Market Capitalization 40.5156 M
Employee 55
Founded 2005
CEO Scott Davis
Website www.eksobionics.com
Headquarter Nevada, United States
FIGI BBG002Z0NKK4
Industry 医疗器械及用品

总收入

净利润

每股基本收益（基本 EPS）

总债务

自由现金流

现金及现金等价物

40.52 M 市值

市盈率

-1.76

市销率

1.64

Ekso Bionics Holdings Inc

Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk. Ekso Bionics currently focuses in the health and industrial sectors. The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community.